Axcella Therapeutics
ClosedCambridge, United States · Founded 2009
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2009
- Business Model
- B2B
- Website
- axcellahealth.com
About
Axcella Health (formerly Axcella Therapeutics, formerly Pronutria Biosciences) was a clinical-stage biotechnology company based in Cambridge, Massachusetts, pioneering the use of endogenous metabolic modulators (EMMs) to treat complex metabolic, muscle, and neurological diseases. Founded in 2009 as a Flagship Pioneering company and listed on Nasdaq (AXLA), it developed multi-targeted EMM compositions informed by systems biology and machine learning. The company shut down in December 2023 following an SEC filing disclosing closure.
Summary
Axcella Therapeutics is a Biotech company based in Cambridge, United States, founded in 2009.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/axcella-therapeutics"><img src="https://indexed.vc/api/badge/company/axcella-therapeutics" alt="Axcella Therapeutics on Indexed.vc" width="260" height="76" /></a>